• E-ISSN 2583-0104
  • Follow us

International Journal of Preclinical and Clinical Research

Article

Surgical Debridement in Patients of Rhinocerebral Mucormycosis (RCM) Post COVID-19: A Prospective Study
  • VIEWS 1215
  • PDF 396

International Journal of Preclinical and Clinical Research

DOI: 10.51131/IJPCCR/v3i3.22.48

Year: 2022, Volume: 3, Issue: 3, Pages: 69-73

Original Article

Surgical Debridement in Patients of Rhinocerebral Mucormycosis (RCM) Post COVID-19: A Prospective Study

Choudhary Shubham​✉ 1 , C K Kiran Kumar 2

1 Postgraduate, Department of General Surgery, Basaveshwara Medical College and hospital, Chitradurga, Karnataka, 577502, India
2 Assistant Professor, Department of General Surgery, Basaveshwara Medical College and Hospital, Chitradurga, Karnataka, 577502, India
 
Corresponding author ✉ : [email protected]

Received Date:28 November 2022, Accepted Date:12 December 2022, Published Date:13 December 2022

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Rhinocerebral mucormycosis (RCM) is an angioinvasive fungal infection, in which infection of the nasal and sinus walls may secondarily invade the orbit, skull base, and brain. RCM carries high mortality up to 46 % in patients with sinus involvement and 62 % in patients with rhinocerebral involvement. The diagnosis of RCM and assessment of the resection margins are based on histopathology, specific cultures, and/or PCR detection of Mucorales species. It was a prospective, longitudinal study conducted under neurosurgery department in Basaveshwara Medical College and Hospital, Chitradurga, Karnataka during 1st May to 30th June 2021. All patients with radiologically, clinically diagnosed & biopsy proven by samples collected intraoperatively are included in the study. Caldwell luc approach was employed for maxillary sinus debridement, FESS for pansinusitis cases & Craniotomy for cases with intracranial involvement. In this study, we found that age, gender, neutrophil counts, monocyte count, ferritin levels, CT severity, diabetic status and usage of steroids and oxygen had a major role in the pathogenesis of mucormycosis. IHC was done and genetic studies were sent. The surgical treatment of RCM requires early diagnosis & aggressive surgical debridement. The outcome of the aggressive debridement was good. The debridement should be continued until clear resection margins are obtained based on the assessment of microscopical findings of hyphae, fungal cultures, and/or fungal DNA detected by PCR.

 

Keywords: Surgical debridement, Rhinocerebral Mucormycosis (RCM), Post COVID-19

References

  1. Jayaweera M, Perera H, Gunawardana B, Manatunge J. Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environmental Research. 2020;188(109819). Available from: https://doi.org/10.1016/j.envres.2020.109819
  2. Mehta S, Pandey A. Rhino-Orbital Mucormycosis Associated With COVID-19. Cureus. 2020;12(9):10726. Available from: https://doi.org/10.7759/cureus.10726
  3. Spellberg B, Edwards J, Ibrahim A. Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management. Clinical Microbiology Reviews. 2005;18(3):556–569. Available from: https://doi.org/10.1128/cmr.18.3.556-569.2005
  4. Jameson JL, Fauci, AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison’s Principles of Internal Medicine (20). (p. 1537) New York. Mc Graw Hills Education. 2018.
  5. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of Mucormycosis. Clinical Infectious Diseases. 2012;54(suppl_1):S16–S22. Available from: https://doi.org/10.1093/cid/cir865
  6. Singh AK, Singh RK, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(4):102146. Available from: https://doi.org/10.1016/j.dsx.2021.05.019
  7. Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(4):102146.
  8. Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest. 1984;74(1):150–160. Available from: https://doi.org/10.1172/JCI111395
  9. Camara-Lemarroy CR, González-Moreno EI, Rodríguez-Gutiérrez R, Rendón-Ramírez EJ, Ayala-Cortés AS, Fraga-Hernández ML, et al. Clinical Features and Outcome of Mucormycosis. Interdisciplinary Perspectives on Infectious Diseases. 2014;2014:1–5. Available from: https://doi.org/10.1155/2014/562610
  10. Hoenigl M, Seidel D, Carvalho A, Rudramurthy SM, Arastehfar A, Gangneux JP, et al. The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries. SSRN Electronic Journal. 2021;p. 1–33. Available from: http://dx.doi.org/10.2139/ssrn.3844587
  11. Patil S, Sarate D, Chopade S, Khade M, Dhage S, Kangate S. Emerging Challenge of Mucormycosis in post-COVID Patients. IAR Journal of Medical Case Reports. 2021;2(3):7–10. Available from: https://doi.org/10.47310/iarjmcr.2021.v02i03.002
  12. Revannavar SM, S SP, Samaga L, K VV. COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world? BMJ Case Reports. 2021;14(4):e241663. Available from: http://dx.doi.org/10.1136/bcr-2021-241663
  13. Symeonidis AS. The role of iron and iron chelators in zygomycosis. Clinical Microbiology and Infection. 2009;15(5):26–32. Available from: https://doi.org/10.1111/j.1469-0691.2009.02976.x
  14. Maini A, Tomar G, Khanna D, Kini Y, Mehta H, Bhagyasree V. Sino-orbital mucormycosis in a COVID-19 patient: A case report. International Journal of Surgery Case Reports. 2021;82:105957. Available from: https://doi.org/10.1016/j.ijscr.2021.105957
  15. Bayram N, Ozsaygılı C, Sav H, Tekin Y, Gundogan M, Pangal E, et al. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Japanese Journal of Ophthalmology. 2021;65(4):515–525. Available from: https://doi.org/10.1007/s10384-021-00845-5
  16. Rammaert B, Lanternier F, Poirée S, Kania R, Lortholary O. Diabetes and mucormycosis: A complex interplay. Diabetes & Metabolism. 2012;38(3):193–204. Available from: https://doi.org/10.1016/j.diabet.2012.01.002
  17. Prakash H, Ghosh AK, Rudramurthy SM, Singh P, Xess I, Savio J, et al. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment. Medical Mycology. 2019;57(4):395–402. Available from: https://doi.org/10.1093/mmy/myy060

Copyright

© 2022 Shubham & Kumar. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Published By Basaveshwara Medical College & Hospital, Chitradurga, Karnataka

  • 13 December 2022

Year: 2022, Volume: 3, Issue: 3


More articles

DON'T MISS OUT!

Subscribe now for latest articles and news.